ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAdolescent and young adult cancer survivors (AYAs; 18-39 years old at initial cancer diagnosis) face unique challenges throughout their disease trajectory and are, therefore, a distinct population within the oncology community. A common side effect of some cancer treatments is neuropathy, which can affect patients' quality of life ongoing. AYA-specific studies on long-term effects, such as neuropathy, are lacking. This study investigated the prevalence of, and factors associated with self-reported peripheral neuropathic symptoms in long-term AYA cancer survivors.
methodsThis questionnaire study (SURVAYA study) examined patient-reported outcomes among long-term AYA cancer survivors (5-20 years post-diagnosis). Data were collected through a questionnaire and by the Netherlands Cancer Registry. Analyses included descriptive statistics and multivariable logistic regression.
resultsThree thousand seven hundred forty-one AYAs were included in this secondary analysis. Overall, the prevalence of self-reported peripheral neuropathic symptoms was 19.8% and was higher among AYA cancer survivors who received chemotherapy. In addition, female sex, older age at diagnosis, primary education or none, secondary vocational education, higher vocational education, head and neck cancer, germ cell tumours, lymphoid haematological malignancies, thyroid cancer, current or former smoking, higher physical activity levels and rheumatoid arthritis were associated with a higher likelihood of reporting peripheral neuropathic symptoms.
conclusionThis study highlights the socio-demographic, clinical and health and lifestyle factors associated with self-reported peripheral neuropathic symptoms in Dutch long-term AYA cancer survivors. This can inform healthcare providers to further identify high-risk groups within the AYA cancer survivors and provide additional monitoring of these patients. Future research should include a longitudinal assessment of peripheral neuropathic symptoms, including baseline scores which were not available in this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.